25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

JENBURPH (Jenburkt) Stock Analysis
Buy, Hold or Sell?

Let's analyze Jenburkt together

I guess you are interested in JENBURKT PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Jenburkt’s Financial Insights
  • 📈 Technical Analysis (TA) – Jenburkt’s Price Targets

I'm going to help you getting a better view of JENBURKT PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about JENBURKT PHARMACEUTICALS LTD.

I send you an email if I find something interesting about JENBURKT PHARMACEUTICALS LTD..

1. Quick Overview

1.1. Quick analysis of Jenburkt (30 sec.)










1.2. What can you expect buying and holding a share of Jenburkt? (30 sec.)

How much money do you get?

How much money do you get?
INR0.72
When do you have the money?
1 year
How often do you get paid?
85.7%

What is your share worth?

Current worth
INR389.23
Expected worth in 1 year
INR632.46
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR304.69
Return On Investment
22.9%

For what price can you sell your share?

Current Price per Share
INR1,328.40
Expected price per share
INR1,177 - INR
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Jenburkt (5 min.)




Live pricePrice per Share (EOD)
INR1,328.40
Intrinsic Value Per Share
INR128.30 - INR277.13
Total Value Per Share
INR517.52 - INR666.36

2.2. Growth of Jenburkt (5 min.)




Is Jenburkt growing?

Current yearPrevious yearGrowGrow %
How rich?$20m$16.9m$3.1m15.6%

How much money is Jenburkt making?

Current yearPrevious yearGrowGrow %
Making money$3.7m$3m$711.7k19.0%
Net Profit Margin21.1%18.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Jenburkt (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Jenburkt?

Welcome investor! Jenburkt's management wants to use your money to grow the business. In return you get a share of Jenburkt.

First you should know what it really means to hold a share of Jenburkt. And how you can make/lose money.

Speculation

The Price per Share of Jenburkt is INR1,328. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jenburkt.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jenburkt, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR389.23. Based on the TTM, the Book Value Change Per Share is INR60.81 per quarter. Based on the YOY, the Book Value Change Per Share is INR51.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR15.36 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jenburkt.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.850.1%0.850.1%0.690.1%0.730.1%0.640.0%0.580.0%
Usd Book Value Change Per Share0.710.1%0.710.1%0.600.0%0.520.0%0.500.0%0.650.0%
Usd Dividend Per Share0.180.0%0.180.0%0.170.0%0.160.0%0.120.0%0.120.0%
Usd Total Gains Per Share0.890.1%0.890.1%0.770.1%0.680.1%0.630.0%0.770.1%
Usd Price Per Share11.84-11.84-8.07-9.23-7.80-6.95-
Price to Earnings Ratio13.93-13.93-11.71-12.53-12.07-11.69-
Price-to-Total Gains Ratio13.28-13.28-10.54-14.47-12.87-11.48-
Price to Book Ratio2.60-2.60-2.10-2.37-2.23-2.28-
Price-to-Total Gains Ratio13.28-13.28-10.54-14.47-12.87-11.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.54228
Number of shares64
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.180.12
Usd Book Value Change Per Share0.710.50
Usd Total Gains Per Share0.890.63
Gains per Quarter (64 shares)57.0440.02
Gains per Year (64 shares)228.15160.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14618221831129150
29236444663257310
313854667494386470
4184729902125515630
52309111130157644790
627610931358188772950
7322127515862199011110
83681457181425110301270
94141639204228211591430
104601821227031412871590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%6.00.01.085.7%6.00.01.085.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of JENBURKT PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--60.80960.8090%51.097+19%44.485+37%42.980+41%55.604+9%
Book Value Per Share--389.226389.2260%328.417+19%331.654+17%293.057+33%258.343+51%
Current Ratio--3.0043.0040%6.699-55%4.949-39%4.572-34%4.478-33%
Debt To Asset Ratio--0.1240.1240%0.122+2%0.128-3%0.150-17%0.175-29%
Debt To Equity Ratio--0.1420.1420%0.139+2%0.147-3%0.178-20%0.217-34%
Dividend Per Share--15.36415.3640%14.316+7%14.047+9%10.468+47%10.603+45%
Enterprise Value--4220846610.0004220846610.0000%2841158685.000+49%3269013031.667+29%2750636866.780+53%2433746128.114+73%
Eps--72.64572.6450%58.861+23%62.421+16%54.361+34%49.621+46%
Ev To Sales Ratio--2.7832.7830%2.001+39%2.267+23%2.033+37%1.839+51%
Free Cash Flow Per Share--18.56318.5630%12.620+47%21.684-14%23.699-22%23.480-21%
Free Cash Flow To Equity Per Share--18.56318.5630%12.620+47%21.684-14%23.699-22%19.355-4%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--277.132----------
Intrinsic Value_10Y_min--128.297----------
Intrinsic Value_1Y_max--24.632----------
Intrinsic Value_1Y_min--19.658----------
Intrinsic Value_3Y_max--76.401----------
Intrinsic Value_3Y_min--53.523----------
Intrinsic Value_5Y_max--131.055----------
Intrinsic Value_5Y_min--81.056----------
Market Cap5862627720.000+24%4464935610.0004464935610.0000%3042749685.000+47%3482314365.000+28%2975184466.780+50%2664744270.971+68%
Net Profit Margin--0.2110.2110%0.183+16%0.192+10%0.181+17%0.170+24%
Operating Margin----0%-0%-0%-0%0.048-100%
Operating Ratio--0.9470.9470%0.997-5%0.995-5%1.031-8%1.057-10%
Pb Ratio3.413+24%2.5992.5990%2.099+24%2.367+10%2.234+16%2.284+14%
Pe Ratio18.286+24%13.92713.9270%11.713+19%12.528+11%12.065+15%11.693+19%
Price Per Share1328.400+24%1011.7001011.7000%689.450+47%789.050+28%666.440+52%593.607+70%
Price To Free Cash Flow Ratio71.562+24%54.50154.5010%54.6300%42.932+27%36.122+51%30.922+76%
Price To Total Gains Ratio17.439+24%13.28213.2820%10.540+26%14.468-8%12.866+3%11.483+16%
Quick Ratio--2.0412.0410%5.453-63%3.826-47%3.535-42%3.546-42%
Return On Assets--0.1630.1630%0.157+4%0.165-1%0.157+4%0.160+2%
Return On Equity--0.1870.1870%0.179+4%0.189-1%0.185+1%0.195-4%
Total Gains Per Share--76.17376.1730%65.413+16%58.533+30%53.448+43%66.207+15%
Usd Book Value--20097920.70020097920.7000%16958015.100+19%17125176.900+17%15325968.060+31%13579115.271+48%
Usd Book Value Change Per Share--0.7110.7110%0.598+19%0.520+37%0.503+41%0.651+9%
Usd Book Value Per Share--4.5544.5540%3.842+19%3.880+17%3.429+33%3.023+51%
Usd Dividend Per Share--0.1800.1800%0.168+7%0.164+9%0.122+47%0.124+45%
Usd Enterprise Value--49383905.33749383905.3370%33241556.615+49%38247452.471+29%32182451.341+53%28474829.699+73%
Usd Eps--0.8500.8500%0.689+23%0.730+16%0.636+34%0.581+46%
Usd Free Cash Flow--958510.800958510.8000%651654.900+47%1119674.400-14%1245731.760-23%1241607.343-23%
Usd Free Cash Flow Per Share--0.2170.2170%0.148+47%0.254-14%0.277-22%0.275-21%
Usd Free Cash Flow To Equity Per Share--0.2170.2170%0.148+47%0.254-14%0.277-22%0.226-4%
Usd Market Cap68592744.324+24%52239746.63752239746.6370%35600171.315+47%40743078.071+28%34809658.261+50%31177507.970+68%
Usd Price Per Share15.542+24%11.83711.8370%8.067+47%9.232+28%7.797+52%6.945+70%
Usd Profit--3751090.2003751090.2000%3039344.100+23%3223151.100+16%2841801.300+32%2609298.900+44%
Usd Revenue--17747905.50017747905.5000%16610080.500+7%16762141.500+6%15500127.240+15%15108607.800+17%
Usd Total Gains Per Share--0.8910.8910%0.765+16%0.685+30%0.625+43%0.775+15%
 EOD+4 -4MRQTTM+0 -0YOY+30 -73Y+23 -145Y+26 -1110Y+25 -13

3.3 Fundamental Score

Let's check the fundamental score of JENBURKT PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.286
Price to Book Ratio (EOD)Between0-13.413
Net Profit Margin (MRQ)Greater than00.211
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.041
Current Ratio (MRQ)Greater than13.004
Debt to Asset Ratio (MRQ)Less than10.124
Debt to Equity Ratio (MRQ)Less than10.142
Return on Equity (MRQ)Greater than0.150.187
Return on Assets (MRQ)Greater than0.050.163
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of JENBURKT PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,366.250
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About JENBURKT PHARMACEUTICALS LTD.

Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical and healthcare products in India. It offers products in various therapeutic areas, such as pain management, analgesic and anti-pyretics, muscle relaxants, nutraceuticals, neuropathic pain, anti-arthritic, anti-infectives, antifungals, antiulcerants/antacids, aphrodisiacs, antimalarials, anthelmintics, cough and cold, and anti- diabetics, as well as consumer products. The company offers its products under the Allerzine, CartiSafe Forte, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, Zydol Suspension, and Zixa brand names. The company provides its products through stockists, doctors, pharmacies, chemists, large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. It exports its products to approximately 13 countries worldwide. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2025-07-10 10:50:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Jenburkt earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Jenburkt to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 21.1% means that ₹0.21 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 21.1%. The company is making a huge profit. +2
  • The TTM is 21.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ21.1%TTM21.1%0.0%
TTM21.1%YOY18.3%+2.8%
TTM21.1%5Y18.1%+3.0%
5Y18.1%10Y17.0%+1.1%
4.3.1.2. Return on Assets

Shows how efficient Jenburkt is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jenburkt to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.3% Return on Assets means that Jenburkt generated ₹0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 16.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 16.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.3%TTM16.3%0.0%
TTM16.3%YOY15.7%+0.6%
TTM16.3%5Y15.7%+0.6%
5Y15.7%10Y16.0%-0.3%
4.3.1.3. Return on Equity

Shows how efficient Jenburkt is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jenburkt to the Drug Manufacturers - Specialty & Generic industry mean.
  • 18.7% Return on Equity means Jenburkt generated ₹0.19 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 18.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.7%TTM18.7%0.0%
TTM18.7%YOY17.9%+0.7%
TTM18.7%5Y18.5%+0.2%
5Y18.5%10Y19.5%-1.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of JENBURKT PHARMACEUTICALS LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Jenburkt is operating .

  • Measures how much profit Jenburkt makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jenburkt to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y4.8%-4.8%
4.3.2.2. Operating Ratio

Measures how efficient Jenburkt is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are ₹0.95 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 0.947. The company is less efficient in keeping operating costs low.
  • The TTM is 0.947. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.947TTM0.9470.000
TTM0.947YOY0.997-0.050
TTM0.9475Y1.031-0.084
5Y1.03110Y1.057-0.026
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of JENBURKT PHARMACEUTICALS LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Jenburkt is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.00 means the company has ₹3.00 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 3.004. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.004. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.004TTM3.0040.000
TTM3.004YOY6.699-3.696
TTM3.0045Y4.572-1.568
5Y4.57210Y4.478+0.094
4.4.3.2. Quick Ratio

Measures if Jenburkt is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jenburkt to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.04 means the company can pay off ₹2.04 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 2.041. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.041. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.041TTM2.0410.000
TTM2.041YOY5.453-3.412
TTM2.0415Y3.535-1.494
5Y3.53510Y3.546-0.011
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of JENBURKT PHARMACEUTICALS LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Jenburkt assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jenburkt to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.12 means that Jenburkt assets are financed with 12.4% credit (debt) and the remaining percentage (100% - 12.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 0.124. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.124. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.124TTM0.1240.000
TTM0.124YOY0.122+0.002
TTM0.1245Y0.150-0.026
5Y0.15010Y0.175-0.025
4.5.4.2. Debt to Equity Ratio

Measures if Jenburkt is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jenburkt to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 14.2% means that company has ₹0.14 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 0.142. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.142. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.142TTM0.1420.000
TTM0.142YOY0.139+0.003
TTM0.1425Y0.178-0.036
5Y0.17810Y0.217-0.039
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Jenburkt generates.

  • Above 15 is considered overpriced but always compare Jenburkt to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 13.93 means the investor is paying ₹13.93 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The EOD is 18.286. Based on the earnings, the company is fair priced.
  • The MRQ is 13.927. Based on the earnings, the company is underpriced. +1
  • The TTM is 13.927. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD18.286MRQ13.927+4.360
MRQ13.927TTM13.9270.000
TTM13.927YOY11.713+2.213
TTM13.9275Y12.065+1.861
5Y12.06510Y11.693+0.373
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The EOD is 71.562. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 54.501. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 54.501. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD71.562MRQ54.501+17.061
MRQ54.501TTM54.5010.000
TTM54.501YOY54.630-0.129
TTM54.5015Y36.122+18.379
5Y36.12210Y30.922+5.200
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Jenburkt is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.60 means the investor is paying ₹2.60 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The EOD is 3.413. Based on the equity, the company is fair priced.
  • The MRQ is 2.599. Based on the equity, the company is underpriced. +1
  • The TTM is 2.599. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.413MRQ2.599+0.814
MRQ2.599TTM2.5990.000
TTM2.599YOY2.099+0.500
TTM2.5995Y2.234+0.365
5Y2.23410Y2.284-0.050
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,961,860
Total Liabilities244,089
Total Stockholder Equity1,717,771
 As reported
Total Liabilities 244,089
Total Stockholder Equity+ 1,717,771
Total Assets = 1,961,860

Assets

Total Assets1,961,860
Total Current Assets565,315
Long-term Assets1,396,544
Total Current Assets
Cash And Cash Equivalents 73,648
Short-term Investments 176,841
Net Receivables 207,349
Inventory 88,803
Other Current Assets 16,573
Total Current Assets  (as reported)565,315
Total Current Assets  (calculated)563,214
+/- 2,101
Long-term Assets
Property Plant Equipment 547,058
Intangible Assets 2,279
Long-term Assets Other 27,654
Long-term Assets  (as reported)1,396,544
Long-term Assets  (calculated)576,991
+/- 819,553

Liabilities & Shareholders' Equity

Total Current Liabilities188,193
Long-term Liabilities55,896
Total Stockholder Equity1,717,771
Total Current Liabilities
Short Long Term Debt 19,788
Accounts payable 81,553
Other Current Liabilities 16,929
Total Current Liabilities  (as reported)188,193
Total Current Liabilities  (calculated)118,270
+/- 69,923
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt19,150
Long-term Liabilities  (as reported)55,896
Long-term Liabilities  (calculated)19,150
+/- 36,746
Total Stockholder Equity
Total Stockholder Equity (as reported)1,717,771
Total Stockholder Equity (calculated)0
+/- 1,717,771
Other
Capital Stock44,133
Common Stock Shares Outstanding 4,413
Net Invested Capital 1,737,559
Net Working Capital 377,122
Property Plant and Equipment Gross 547,058



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
1,028,249
1,040,698
1,211,831
1,429,491
1,418,121
1,650,994
1,961,860
1,961,8601,650,9941,418,1211,429,4911,211,8311,040,6981,028,24900
   > Total Current Assets 
638,859
659,216
896,680
895,427
799,873
759,042
810,906
1,097,278
565,315
565,3151,097,278810,906759,042799,873895,427896,680659,216638,859
       Cash And Cash Equivalents 
0
0
12,268
25,340
24,937
50,314
36,599
41,254
73,648
73,64841,25436,59950,31424,93725,34012,26800
       Short-term Investments 
0
0
510,977
520,179
495,137
415,545
458,245
698,437
176,841
176,841698,437458,245415,545495,137520,179510,97700
       Net Receivables 
119,366
147,670
256,457
222,801
140,007
152,068
169,616
194,752
207,349
207,349194,752169,616152,068140,007222,801256,457147,670119,366
       Inventory 
107,457
68,044
98,312
108,987
75,815
98,877
83,376
85,617
88,803
88,80385,61783,37698,87775,815108,98798,31268,044107,457
       Other Current Assets 
8,411
28,226
13,767
13,304
11,692
60
1,379
14,270
16,573
16,57314,2701,3796011,69213,30413,76728,2268,411
   > Long-term Assets 
0
0
131,570
145,272
411,961
670,450
607,621
557,084
1,396,544
1,396,544557,084607,621670,450411,961145,272131,57000
       Property Plant Equipment 
104,981
94,491
104,216
110,033
104,468
224,053
227,101
365,454
547,058
547,058365,454227,101224,053104,468110,033104,21694,491104,981
       Goodwill 
0
0
14
14
14
0
0
0
0
000014141400
       Intangible Assets 
0
0
11,490
8,414
4,797
3,056
1,874
3,876
2,279
2,2793,8761,8743,0564,7978,41411,49000
       Long-term Assets Other 
0
0
0
0
910
113,097
120,233
254,589
27,654
27,654254,589120,233113,0979100000
> Total Liabilities 
0
0
253,594
240,655
227,168
255,666
194,224
201,591
244,089
244,089201,591194,224255,666227,168240,655253,59400
   > Total Current Liabilities 
182,957
130,694
226,156
198,008
179,919
212,798
157,619
163,787
188,193
188,193163,787157,619212,798179,919198,008226,156130,694182,957
       Short Long Term Debt 
0
0
74,693
34,389
37,106
58,152
24,389
0
19,788
19,788024,38958,15237,10634,38974,69300
       Accounts payable 
60,162
41,221
65,490
52,264
45,924
71,104
60,968
62,572
81,553
81,55362,57260,96871,10445,92452,26465,49041,22160,162
       Other Current Liabilities 
54,394
83,376
77,743
85,778
10,640
11,522
11,477
16,298
16,929
16,92916,29811,47711,52210,64085,77877,74383,37654,394
   > Long-term Liabilities 
0
0
27,440
42,647
47,249
42,868
36,605
37,804
55,896
55,89637,80436,60542,86847,24942,64727,44000
       Capital Lease Obligations Min Short Term Debt
0
0
0
17,409
13,563
9,397
4,886
0
19,150
19,15004,8869,39713,56317,409000
       Long-term Liabilities Other 
0
0
27,440
29,084
-1
0
-1
0
0
00-10-129,08427,44000
> Total Stockholder Equity
0
0
774,655
800,043
984,663
1,173,825
1,223,897
1,449,403
1,717,771
1,717,7711,449,4031,223,8971,173,825984,663800,043774,65500
   Common Stock
46,493
46,493
45,894
45,894
0
0
0
0
0
0000045,89445,89446,49346,493
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
7,404
518
1,142
-23,396
0
0
0
0
0
00000-23,3961,1425187,404



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,516,915
Cost of Revenue-296,565
Gross Profit1,220,3501,220,350
 
Operating Income (+$)
Gross Profit1,220,350
Operating Expense-1,140,269
Operating Income376,64680,081
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense1,140,2690
 
Net Interest Income (+$)
Interest Income0
Interest Expense-4,528
Other Finance Cost-0
Net Interest Income-4,528
 
Pretax Income (+$)
Operating Income376,646
Net Interest Income-4,528
Other Non-Operating Income Expenses0
Income Before Tax (EBT)439,328376,646
EBIT - interestExpense = -4,528
320,606
325,134
Interest Expense4,528
Earnings Before Interest and Taxes (EBIT)0443,856
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax439,328
Tax Provision-118,722
Net Income From Continuing Ops320,606320,606
Net Income320,606
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net04,528
 

Technical Analysis of Jenburkt
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jenburkt. The general trend of Jenburkt is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jenburkt's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Jenburkt Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of JENBURKT PHARMACEUTICALS LTD..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 1,337 > 1,332 > 1,177.

Know someone who trades $JENBURPH? Share this with them.👇

JENBURKT PHARMACEUTICALS LTD. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of JENBURKT PHARMACEUTICALS LTD.. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

JENBURKT PHARMACEUTICALS LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) ChartJENBURKT PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of JENBURKT PHARMACEUTICALS LTD.. The current adx is .

JENBURKT PHARMACEUTICALS LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) ChartJENBURKT PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Stochastic Oscillator ChartJENBURKT PHARMACEUTICALS LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) ChartJENBURKT PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) ChartJENBURKT PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Williams %R ChartJENBURKT PHARMACEUTICALS LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Average True Range (ATR) ChartJENBURKT PHARMACEUTICALS LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) ChartJENBURKT PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) ChartJENBURKT PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for JENBURKT PHARMACEUTICALS LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

JENBURKT PHARMACEUTICALS LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of JENBURKT PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,366.250
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Jenburkt with someone you think should read this too:
  • Are you bullish or bearish on Jenburkt? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jenburkt? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about JENBURKT PHARMACEUTICALS LTD.

I send you an email if I find something interesting about JENBURKT PHARMACEUTICALS LTD..


Comments

How you think about this?

Leave a comment

Stay informed about JENBURKT PHARMACEUTICALS LTD..

Receive notifications about JENBURKT PHARMACEUTICALS LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.